“…The specific fasting glucose level at trial entry was reported in 14 studies ( 19 , 21 – 26 , 36 , 37 , 39 – 43 ), with a mean level ranging from 4.65 ± 0.50 ( 23 ) to 10.05 ± 1.61 ( 37 ) mmol/L. Maternal BMI at trial entry and before pregnancy was reported in eight studies ( 19 , 24 , 25 , 38 , 39 , 41 , 42 , 44 ) and seven studies ( 22 , 23 , 26 , 35 , 36 , 40 , 43 ), respectively. As for treatments of the intervention groups, the comprehensive intervention was utilized in seven studies ( 19 – 21 , 23 , 24 , 26 , 43 ), a calorie/carbohydrate-restricted diet was utilized in three studies ( 37 , 41 , 42 ), vitamin D supplements were utilized in two studies ( 25 , 35 ), probiotics were utilized in two studies ( 25 , 44 ), and phytosterol-enriched food ( 36 ), omega-3 fatty acids plus vitamin E supplements ( 38 ), vitamin C supplements ( 39 ), docosahexaenoic acid (DHA) supplements ( 40 ), and epigallocatechin 3-gallate (EGCG) supplements ( 22 ) were used in every single study.…”